Literature DB >> 6785294

Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: characterization of the abnormal hormone.

I Z Beitins, L Axelrod, T Ostrea, R Little, T M Badger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6785294     DOI： 10.1210/jcem-52-6-1143

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Dissociated effect of buserelin on luteinizing hormone (LH) and alpha subunit in men.

Authors:  G Valenti; L Denti; A Banchini; G Ceresini; G P Ceda; W C Westel; A Negro-Vilar
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

2.  Age and sex related variations in biologically active and immunoreactive serum luteinizing hormone.

Authors:  P Marrama; A A Zaidi; V Montanini; M F Celani; K Cioni; C Carani; F Morabito; M Resentini; B Bonati; G F Baraghini
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

3.  A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

Authors:  R M Evans; G C Doelle; J Lindner; V Bradley; D Rabin
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

4.  Delayed puberty in uremia: pituitary-gonadal function during short-term pulsatile luteinizing hormone-releasing hormone administration.

Authors:  M Giusti; F Perfumo; E Verrina; D Cavallero; G Piaggio; S Valenti; R Gusmano; G Giordano
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

5.  Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.

Authors:  M F Celani; V Montanini; G F Baraghini; C Carani; P Marrama
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.